Acrotech Biopharma
FDA Approved Drugs

Acrotech Biopharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 10
  • Latest Approval Date Feb 12, 2026
  • Data Source FDA
  • First Approval Date Mar 07, 2008
All
10
View
Discontinued
4
View
RX
6
View
Company Overview

Company

Acrotech Biopharma

Country

U.S.A

Website

Visit Website

Email

info@AcrotechBiopharma.com

Social Profiles

LinkedIn
Company Snapshot

Acrotech Biopharma

279 Princeton Hightstown Rd., East Windsor, NJ 08520 (866) 850-2876

U.S.A

acrotechbiopharma.com/ info@AcrotechBiopharma.com View on Map
FDA Approved Drug Records ( 10 records )
2026
12 Feb
RX Application: 219474

Drug Name

ADQUEY

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2026-02-12

219474 / 1

Active Ingredient

DIFAMILAST

Application Number

219474

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2026-02-12

Regulatory Status

RX

2014
03 Jul
RX Application: 206256

Drug Name

BELEODAQ

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2014-07-03

206256 / 1

Active Ingredient

BELINOSTAT

Application Number

206256

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2014-07-03

Regulatory Status

RX

2016
10 Mar
RX Application: 207155

Drug Name

EVOMELA

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2016-03-10

207155 / 1

Active Ingredient

MELPHALAN HYDROCHLORIDE

Application Number

207155

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2016-03-10

Regulatory Status

RX

2009
24 Sep
RX Application: 22468

Drug Name

FOLOTYN

Product Number

1

Dosage Form

-

Strength

20MG/ML (20MG/ML)

Approval Date

2009-09-24

22468 / 1

Active Ingredient

PRALATREXATE

Application Number

22468

Product Number

1

Dosage Form

-

Strength

20MG/ML (20MG/ML)

Approval Date

2009-09-24

Regulatory Status

RX

2009
24 Sep
RX Application: 22468

Drug Name

FOLOTYN

Product Number

2

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2009-09-24

22468 / 2

Active Ingredient

PRALATREXATE

Application Number

22468

Product Number

2

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2009-09-24

Regulatory Status

RX

2008
07 Mar
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2008-03-07

20140 / 1

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2008-03-07

Regulatory Status

Discontinued

2011
29 Apr
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

2

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

20140 / 2

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

2

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

Regulatory Status

Discontinued

2011
29 Apr
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

3

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

20140 / 3

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

3

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

Regulatory Status

Discontinued

2018
19 Oct
RX Application: 211226

Drug Name

KHAPZORY

Product Number

1

Dosage Form

-

Strength

175MG/VIAL

Approval Date

2018-10-19

211226 / 1

Active Ingredient

LEVOLEUCOVORIN

Application Number

211226

Product Number

1

Dosage Form

-

Strength

175MG/VIAL

Approval Date

2018-10-19

Regulatory Status

RX

2018
19 Oct
Discontinued Application: 211226

Drug Name

KHAPZORY

Product Number

2

Dosage Form

-

Strength

300MG/VIAL

Approval Date

2018-10-19

211226 / 2

Active Ingredient

LEVOLEUCOVORIN

Application Number

211226

Product Number

2

Dosage Form

-

Strength

300MG/VIAL

Approval Date

2018-10-19

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    10 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ADQUEY

Application Number

219474

Product Number

1

Active Ingredient

DIFAMILAST

Dosage Form

-

Strength

1%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit